TDM-105795 showed promisinghairgrowth results, with higher efficacy than placebo and minimal side effects. It activates dormant hair follicle stem cells and may maintain gains without immediate loss, unlike minoxidil.
PP405 is a promising new treatment for hair loss that activates dormant stem cells in hair follicles, potentially bypassing the effects of DHT. It is currently in phase 2 trials and could be available between 2027 and 2030, but it is not considered a definitive cure.
JW0061 shows superior hairgrowth results compared to existing treatments, with significant increases in hair follicles. The Wnt/β-catenin pathway is crucial for hairgrowth, and JW0061 activates this pathway effectively.
The conversation is about hair loss treatments, specifically discussing the effectiveness of Red Ginseng Extract in promotinghairgrowth. Other treatments mentioned include Minoxidil, finasteride, and RU58841.
Hair loss is linked to scalp fibrosis and tension, which result from chronic mechanical stress and androgenic signaling. Treatments include blocking androgens with finasteride, promotinghairgrowth with topical minoxidil, and improving scalp mobility through exercises.